Suchergebnisse - "Adenosine Monophosphate/adverse effects"

Safety and Efficacy of Cangrelor in Acute Stroke Treated with Mechanical Thrombectomy: Endovascular Treatment of Ischemic Stroke Registry and Meta-analysis

Autoren: Marnat, G. Finistis, S. Delvoye, F. et al.

Weitere Verfasser: Marnat, G. Finistis, S. Delvoye, F. et al.

Quelle: American Journal of Neuroradiology. 43:410-415

Schlagwörter: Radiology, Nuclear Medicine and Imaging, Arterial Occlusive Diseases, Sciences de la santé humaine, Adenosine Monophosphate/analogs & derivatives, Brain Ischemia, Adenosine Monophosphate/therapeutic use, 03 medical and health sciences, 0302 clinical medicine, Neurologie, Ischemic Stroke/therapy, Multicenter Studies as Topic, Humans, [SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC], Prospective Studies, Registries, Adenosine Monophosphate/adverse effects, Human health sciences, Retrospective Studies, Cerebral Hemorrhage, Ischemic Stroke, Thrombectomy, Endovascular Procedures, Cerebral Hemorrhage/etiology, Combined Modality Therapy, Adenosine Monophosphate, 3. Good health, Stroke, Treatment Outcome, Neurology, Stents, Neurology (clinical), cangrelor

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/35241418

Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels: A Randomized Controlled Trial

Autoren: Jens D. Lundgren Birgit Grund Christina E. Barkauskas et al.

Quelle: Annals of Internal Medicine
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
instname
ACTIV-3/TICO Bamlanivimab Study Group & Nielsen, H 2022, 'Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial', Annals of Internal Medicine, vol. 175, no. 2, pp. 234–243. https://doi.org/10.7326/M21-3507
ACTIV-3/TICO Bamlanivimab Study Group* & Johansen, I S 2022, ' Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial ', Annals of Internal Medicine, vol. 175, no. 2, pp. 234-243 . https://doi.org/10.7326/M21-3507
ACTIV-3/TICO Bamlanivimab Study Group & Østergaard, L J 2022, 'Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial', Annals of Internal Medicine, vol. 175, no. 2, pp. 234-243. https://doi.org/10.7326/M21-3507

Schlagwörter: Male, 0301 basic medicine, COVID-19/blood, Antibodies, Monoclonal, Humanized, Antiviral Agents, 12. Responsible consumption, 03 medical and health sciences, Double-Blind Method, Humans, RNA, Viral/blood, Treatment Failure, Adenosine Monophosphate/adverse effects, Antigens, Viral, Aged, 0303 health sciences, Alanine, SARS-CoV-2, COVID-19, Middle Aged, 16. Peace & justice, Antiviral Agents/adverse effects, Antibodies, Neutralizing, Antibodies, Neutralizing/adverse effects, Adenosine Monophosphate, COVID-19 Drug Treatment, 3. Good health, Antigens, Viral/blood, Antibodies, Monoclonal, Humanized/adverse effects, Alanine/adverse effects, RNA, Viral, Drug Therapy, Combination, Female, Medical Futility, Biomarkers/blood, Biomarkers

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/34928698
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=5085
https://vbn.aau.dk/da/publications/c530ec33-9c51-477d-98fa-36df01391484
http://www.scopus.com/inward/record.url?scp=85122944410&partnerID=8YFLogxK
https://doi.org/10.7326/M21-3507
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334931/pdf/nihms-1818621.pdf
https://portal.findresearcher.sdu.dk/da/publications/45f270f1-41e6-4078-b1c4-3181574e6306
https://doi.org/10.7326/M21-3507
https://portal.findresearcher.sdu.dk/da/publications/45f270f1-41e6-4078-b1c4-3181574e6306

Cardiovascular events and safety outcomes associated with remdesivir using a World Health Organization international pharmacovigilance database

Autoren: Nam Kyun Kim Marco Solmi Salvatore Terrazzino et al.

Weitere Verfasser: Nam Kyun Kim Marco Solmi Salvatore Terrazzino et al.

Quelle: Clin Transl Sci
CTS-CLINICAL AND TRANSLATIONAL SCIENCE
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Clinical and Translational Science, Vol 15, Iss 2, Pp 501-513 (2022)

Schlagwörter: Alanine / adverse effects, Adenosine Monophosphate / adverse effects, Adenosine Monophosphate / analogs & derivatives, Antiviral Agents / adverse effects, Databases, Factual, [SDV]Life Sciences [q-bio], RM1-950, World Health Organization, Antiviral Agents, Databases, Pharmacovigilance, 03 medical and health sciences, 0302 clinical medicine, Annan medicinsk grundvetenskap, Humans, Myocytes, Cardiac, Other Basic Medicine, Factual, Retrospective Studies, Myocytes, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, Alanine, SARS-CoV-2, Research, VIGIBASE, COVID-19, 16. Peace & justice, Adenosine Monophosphate, COVID-19 Drug Treatment, 3. Good health, [SDV] Life Sciences [q-bio], Alanine / analogs & derivatives, COVID-19 / drug therapy, Cardiovascular Diseases / chemically induced, Cardiovascular Diseases, Cardiac / drug effects, Therapeutics. Pharmacology, Public aspects of medicine, RA1-1270, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

Dateibeschreibung: application/pdf; STAMPA

Zugangs-URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.13168
https://pubmed.ncbi.nlm.nih.gov/34719115
https://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=20245
https://ascpt.onlinelibrary.wiley.com/doi/10.1111/cts.13168
https://arro.anglia.ac.uk/id/eprint/707069/11/Jung_et_al_2021.pdf
https://doaj.org/article/193ae135de354dc99bb9951ef20e5f30
https://hal.uvsq.fr/hal-03416916v1
https://pubmed.ncbi.nlm.nih.gov/34719115/
https://www.ncbi.nlm.nih.gov/pubmed/34719115
https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/zh/covidwho-1494654
https://ascpt.onlinelibrary.wiley.com/doi/10.1111/cts.13168
https://arro.anglia.ac.uk/id/eprint/707069/
https://hal.sorbonne-universite.fr/hal-03416916v1
https://hal.sorbonne-universite.fr/hal-03416916v1/document
https://doi.org/10.1111/cts.13168
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-181065

Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study

Autoren: Yannick Degboé François Montastruc Alexis Revet et al.

Weitere Verfasser: Yannick Degboé François Montastruc Alexis Revet et al.

Quelle: Drug Saf
Drug Safety

Schlagwörter: Male, Hallucinations, Databases, Pharmaceutical, Toxicology, Lopinavir, MESH: Adenosine Monophosphate / analogs & derivatives, 0302 clinical medicine, Monoclonal, 80 and over, Pharmacology (medical), Original Research Article, MESH: Lopinavir / adverse effects, MESH: Aged, Aged, 80 and over, Alanine, Mental Disorders, MESH: Hallucinations / chemically induced, Middle Aged, 3. Good health, Drug Combinations, MESH: Hydroxychloroquine / adverse effects, MESH: COVID-19 Drug Treatment, Female, Hydroxychloroquine, Adult, Humanized / adverse effects, Antibodies, Monoclonal, Humanized, Antiviral Agents, MESH: Databases, MESH: Antiviral Agents / adverse effects, Psychoses, Substance-Induced, 03 medical and health sciences, Humans, MESH: Hallucinations / epidemiology, Aged, MESH: Drug Combinations, Pharmacology, MESH: Adenosine Monophosphate / adverse effects, MESH: Humans, Ritonavir, MESH: Antibodies, MESH: Adult, MESH: Alanine / analogs & derivatives, MESH: Male, Adenosine Monophosphate, Pharmaceutical, MESH: Alanine / adverse effects, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, MESH: Female, Self-Injurious Behavior

Zugangs-URL: https://link.springer.com/content/pdf/10.1007/s40264-020-01013-3.pdf
https://pubmed.ncbi.nlm.nih.gov/33078372

Neuropsychological adverse drug reactions of Remdesivir: analysis using VigiBase, the WHO global database of individual case safety reports

Weitere Verfasser: S Lee J W Yang S Y Jung et al.

Schlagwörter: Adenosine Monophosphate / adverse effects, Adenosine Monophosphate / analogs & derivatives, Adverse Drug Reaction Reporting Systems, Alanine / adverse effects, Alanine / analogs & derivatives, Bayes Theorem, Cohort Studies, Databases, Factual, Humans, Nervous System Diseases / chemically induced, Nervous System Diseases / epidemiology, Pharmacovigilance, Psychological Distress, Stress, Psychological / chemically induced, Psychological / epidemiology, World Health Organization

Relation: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES; J03872; https://ir.ymlib.yonsei.ac.kr/handle/22282913/187792; T202125316

Verfügbarkeit: https://ir.ymlib.yonsei.ac.kr/handle/22282913/187792
https://doi.org/10.26355/eurrev_202112_27435

Safety and Efficacy of Cangrelor in Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis

Autoren: Reda Mostafa, Mostafa Eid, Mohamed Magdi Awad, Ahmed K et al.

Quelle: Rochester Regional Health authored publications and proceedings

Schlagwörter: Humans, Clopidogrel (therapeutic use), Acute Coronary Syndrome (therapy), Platelet Aggregation Inhibitors (adverse effects), Network Meta-Analysis, Purinergic P2Y Receptor Antagonists (adverse effects), Adenosine Monophosphate (adverse effects), Myocardial Infarction (drug therapy), Hemorrhage (chemically induced, epidemiology, drug therapy), Percutaneous Coronary Intervention (adverse effects, methods), Treatment Outcome, Thrombosis (drug therapy), Medicine and Health Sciences

Relation: https://scholar.rochesterregional.org/rrhpubs/2183

Verfügbarkeit: https://scholar.rochesterregional.org/rrhpubs/2183
https://doi.org/10.1007/s40256-023-00616-2

Safety and Efficacy of Cangrelor in Acute Stroke Treated with Mechanical Thrombectomy: Endovascular Treatment of Ischemic Stroke Registry and Meta-analysis.

Autoren: Marnat, G Finistis, S Delvoye, François et al.

Quelle: American Journal of Neuroradiology, 43 (3), 410 - 415 (2022-03)

Schlagwörter: Adenosine Monophosphate, cangrelor, Cerebral Hemorrhage/etiology, Combined Modality Therapy, Humans, Ischemic Stroke/therapy, Treatment Outcome, Adenosine Monophosphate/adverse effects, Adenosine Monophosphate/analogs & derivatives, Adenosine Monophosphate/therapeutic use, Endovascular Procedures, Thrombectomy, Arterial Occlusive Diseases, Brain Ischemia, Cerebral Hemorrhage, Ischemic Stroke, Multicenter Studies as Topic, Prospective Studies, Registries, Retrospective Studies, Stents, Stroke, Radiology, Nuclear Medicine and Imaging, Neurology (clinical), Human health sciences, Neurology, Sciences de la santé humaine, Neurologie

Relation: https://syndication.highwire.org/content/doi/10.3174/ajnr.A7430; urn:issn:0195-6108; urn:issn:1936-959X

Zugangs-URL: https://orbi.uliege.be/handle/2268/324568

Adverse effects of remdesivir, hydroxychloroquine, and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomized trials

Autoren: Izcovich, Ariel Siemieniuk, Reed Alexander Bartoszko, Jessica Julia et al.

Quelle: BMJ Open
BMJ Open, Vol 12, Iss 3 (2022)

Schlagwörter: Alanine / adverse effects, Adenosine Monophosphate / adverse effects, Alanine, Ritonavir, SARS-CoV-2, Ritonavir / adverse effects, Lopinavir / adverse effects, Adenosine Monophosphate / analogs & derivatives, Adenosine Monophosphate, Lopinavir, COVID-19 Drug Treatment, 3. Good health, Drug Combinations, Infectious Diseases, Alanine / analogs & derivatives, Medicine, Humans, Hydroxychloroquine / adverse effects, Hydroxychloroquine, Randomized Controlled Trials as Topic

Dateibeschreibung: application/pdf

Zugangs-URL: https://www.medrxiv.org/content/medrxiv/early/2020/11/18/2020.11.16.20232876.full.pdf
https://bmjopen.bmj.com/content/bmjopen/12/3/e048502.full.pdf
https://pubmed.ncbi.nlm.nih.gov/35236729
https://doaj.org/article/b54a90ef65534deab17f82632cf7215b
http://medrxiv.org/cgi/content/short/2020.11.16.20232876
https://www.medrxiv.org/content/10.1101/2020.11.16.20232876v1
https://europepmc.org/article/PPR/PPR239364
https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/en/ppmedrxiv-20232876
https://www.medrxiv.org/content/medrxiv/early/2020/11/18/2020.11.16.20232876.full.pdf